Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03240679 · ClinicalTrials.gov registry record · NA
Endoscopic Mucosal Resection and Cellular Matrix
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT03240679: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT03240679 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03240679, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
This study is being done to test the usefulness of extracellular matrix (ECM) a thin sheet placed over the site after endoscopic mucosal resection to promote healing of the esophagus.
Primary Outcome
Number of subjects to have complete endoscopic submucosal resection (EMR) site healing determined by the ability of the resection site to lift with saline injection during follow-up endoscopy.
Interventions
- DEVICE Acell MatriStem® Surgical Matrix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2017-03-22 |
| Est. Completion | 2017-06-20 |
| Phase | NA |
Why NCT03240679 stopped before completion
NCT03240679 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Acell MatriStem® Surgical Matrix is the first listed.
NCT03240679 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03240679 about?
NCT03240679 is a clinical study titled "Endoscopic Mucosal Resection and Cellular Matrix". This study is being done to test the usefulness of extracellular matrix (ECM) a thin sheet placed over the site after endoscopic mucosal resection to promote healing of the esophagus.
What is the current status of trial NCT03240679?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2017-03-22. Estimated completion is 2017-06-20.
What interventions are being tested in trial NCT03240679?
The interventions under investigation include: Acell MatriStem® Surgical Matrix (DEVICE).
Who is sponsoring clinical trial NCT03240679?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03240679's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI